 Home > Medical News > Latest Medical News > Andorra Pharmaceuticals first researched oral third-generation breast cancer new drug AND019 approved for clinical use in the U.S.

Andorra Pharmaceuticals first researched oral third-generation breast cancer new drug AND019 approved for clinical use in the U.S.

 Last Update: 2021-10-22
 Source: Internet
 Author: User

Tags

world's largest pharmaceutical companies

chemical process

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hangzhou, October 8, 2021/PRNewswire/ - On October 1, the third-generation oral breast cancer class 1 new drug AND019, independently developed by Hangzhou Andao Pharmaceutical Co.

AND019 is an oral third-generation Selective Estrogen Receptor Degraders (SERDs) with a new chemical structure.

The preclinical research results of AND019 show that it has excellent in vivo and in vitro biological activity and good oral absorption characteristics, and has shown a high therapeutic safety window in animal experiments, which allows it to be developed as a first-line concomitant treatment for breast cancer Drugs

Dr.

Hangzhou Andao Pharmaceutical was founded on July 15, 2014 by a number of scientists with many years of industrial experience in large international pharmaceutical companies and innovative biotechnology companies.

Source: Hangzhou Andao Pharmaceutical Co.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.